
The department functions as part of the Division of Diagnostics and Treatment of Hematological Diseases.
The Clinical and Diagnostic Department of Hematology and Myeloid Neoplasia was established in April 2022.
The purpose of the department: the introduction of modern methods of diagnosis and treatment of hematological diseases and myeloid neoplasia, including myelodysplastic syndrome.
The department is advised by leading experts of the NMRC for Hematology.